Clinical Trial Update: Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of asciminib in combination with imatinib in patients with chronic-phase chronic myeloid leukemia who previousl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)
• Imatinib (imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: CML, Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-14